
HOVEDPROGRAM 2026
TORSDAG 19. NOVEMBER
09:00 - 09:15 Åpning
09:15 - 09:55 Sweat, Science, Spandex and Cancer: The Story of the CHALLENGE Trial
Christopher Booth, Queens University and Kingston Health Sciences Centre, Canada
09:55 - 10:15 High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM)
Gitte Holmen Olfusson, University of Copenhagen, Denmark
10:15 - 10:30 Discussion - How do we do it?
Lene Thorsen, Oslo universitetssykehus
10:30 - 11:00 Kaffepause
11:00 - 11:20 Common Sense Oncology: Delivering Outcomes that Matter
Christopher Booth, Queens University and Kingston Health Sciences Centre, Canada
Legeforeningen
11:30 - 11:40 Common Sense Oncology i Norge
Meetali Kakad, Akershus universitetssykehus
11:40 - 11:50 Erfaring Kloke Valg
Oddbjørn Straume, Haukeland universitetssykehus
12:00 - 13:30 Lunsj/utstilling
13:30 - 17:30 Faggruppesesjoner
Norsk Bryst Cancer Gruppe
Norsk Gastrointestinal Cancer Gruppe
Norsk Lunge Cancer Gruppe
Norsk Lymfom Gruppe
Norsk Forening for Gynekologisk Onkologi
Norsk Melanom Gruppe
Norsk Nevroonkologisk Interessegruppe
Norsk Forening for Palliativ Medisin
Norsk Gruppe for Hode Hals Cancer
Norsk Urologisk Cancer Gruppe
Nasjonal Kompetansetjeneste for Seneffekter etter Kreftbehandling
Norsk Presisjonsmedisinsk Cancer Gruppe
FREDAG 20. NOVEMBER
09:00 - 09:30 Geriatric Assessment in Cancer Care and Clinical Trials
Hans Wilders UZ Leuven, Belgium
09:30 - 09:45 Geriatric Oncology in Norway
Nienke de Glas, Helse Førde
09:45 - 10:00 Kong Olav Vs Kreftforskningspris 2026
Johanna Olweus, Oslo universitetssykehus
10:00 - 10:20 Kaffepause
10:20 - 10:35 Onkologisk Forum Karrierestipend 2026
10:35 - 11:05 Managing Immune-Related Adverse Events in Clinical Practice: From Early Detection to Steroid-Refractory Disease and Outpatient Follow-up
Åsmund Flobak, Oslo universitetssykehus
11:05 - 11:35 Radiotherapy in breast cancer 2030 – is there a role for proton therapy and what will we learn from the PARABLE study?
Anna Kirby, Royal Marsden, London, UK
11:35 - 12:15 Lunsj
12:15 - 12:45 How will AI change our radiotherapy practice?
Andrew Hope, Princess Margaret Cancer Center, Canada
12:45 - 13:15 Where are we with clinical AI in oncology - what does the near future look like?
TBC
13:15 - 13:35 Tittel kommer
Magnus Løberg, Universitet i Oslo
13:35 - 13:45 Tittel kommer
Kristine Ramheim Randel, Kreftregisteret
13:45 - 13:55 Tittel kommer
Marius Kuras Skram, Helsedirektoratet
14:00 Avslutning

